Study Focuses on Adolescent Data in Upadacitinib AD Trials ...Middle East

Medscape - News
The JAK inhibitor was generally well tolerated among the adolescents, with mild or moderate acne being the most common adverse event, the authors reported. MDedge News

Hence then, the article about study focuses on adolescent data in upadacitinib ad trials was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Study Focuses on Adolescent Data in Upadacitinib AD Trials )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News